You are in: eMedicine Specialties > Sports Medicine > Introductory Topics in Sports Medicine ContusionsArticle Last Updated: Dec 8, 2005AUTHOR AND EDITOR INFORMATIONAuthor: Brett J Earl, MD, Consulting Staff, Department of Emergency Medicine, Ogden Regional Medical Center and Davis Hospital and Medical Center Brett J Earl is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, and Society for Academic Emergency Medicine Coauthor(s): Michael S Omori, MD, Attending Staff, Emergency Medicine Residency, St Vincent Mercy Medical Center; Acting Director, Pediatric Emergency Center, Mercy Children's Hospital; Clinical Assistant Professor, Department of Surgery, University of Toledo Medical Center; Paul Fenton, MD, Assistant Professor, Department of Orthopaedic Surgery, Division of Sports Medicine, Medical College of Ohio at Toledo Editors: Joseph P Garry, MD, Director of Sports Medicine and Sports Medicine Fellowship, Associate Professor of Family Medicine and Exercise and Sport Science, Department of Family Medicine, East Carolina University Brody School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital; Sherwin SW Ho, MD, Associate Professor, Department of Surgery, Section of Orthopedic Surgery and Rehabilitation Medicine, University of Chicago Author and Editor Disclosure Synonyms and related keywords: bruise, muscle contusions INTRODUCTIONBackgroundMuscle contusion indicates a direct, blunt, compressive force to a muscle. Contusions are one of the most common sports-related injuries. The severity of contusions ranges from simple skin contusions to muscle and bone contusions to internal organ contusions. Although all tissue and organ contusions can result from traumatic sports injury, this article focuses on muscle contusions. Contusions of internal organs and bone contusions are not discussed in this article (see Concussion, Sacroiliac Joint Injury, Femur Injuries and Fractures, and Hip Pointer). FrequencyUnited StatesContusions and strain injuries comprise approximately 60-70% of all sports-related injuries. In addition, most contusion injuries go unreported and untreated. Documented muscle contusions account for one third of all sports injuries. The quadriceps and gastrocnemius muscle groups most often are involved. InternationalInternational frequency is similar to the frequency in the United States. Functional AnatomySkeletal muscle constitutes the largest tissue mass in the body, comprising up to 45% of the total body weight. Muscles that cross a single joint are located close to bone, are frequently responsible for postural maintenance, and are most susceptible to contusions. On the other hand, 2-joint muscles, such as the rectus femoris muscle, lie more superficial and are more susceptible to stretch-induced strain injury. Contusions are caused by blunt trauma to the outer aspect of the muscle, resulting in tissue and cellular damage and bleeding deep within the muscle and between the muscle planes. The resultant tissue necrosis and hematoma lead to inflammation. Little is known about the role of the inflammatory process and its importance in the healing process. Clearly, too much inflammation is unfavorable, but too little may be just as devastating. A bruise is caused by blood that has escaped from damaged capillaries into the interstitial tissues. Within a few hours after the injury, the presence of necrotic tissue and hematoma initiates an inflammatory reaction. Since inflammation initiates macrophage action with subsequent phagocytosis of necrotic debris and stimulation of capillary production, it is vital to the process of muscle regeneration. However, inflammation invariably causes edema that leads to anoxia and further cell death. The extent of the inflammatory response often is considered excessive and detrimental to muscle regeneration. However, controversy exists in this theory because some literature indicates a worsened long-term outcome in patients placed on anti-inflammatory medications. Controversy also surrounds cryotherapy with some literature touting its benefits, while others question its utility. CLINICALHistorySymptoms of a contusion often are nonspecific, and the diagnosis is one of exclusion.
PhysicalOften, the physical examination is most important in excluding other injuries and narrowing the differential. In general, tenderness to palpation and pain with PROM and AROM are the hallmarks of the physical examination. Depending upon the size of the lesion, a hematoma also may be appreciated. A complete examination of the injured area and surrounding areas must be emphasized to identify other possible injuries.
CausesAny blunt trauma with sufficient force to propel its energy into the muscle can cause a contusion. Contusions often are the result of sports-related injuries. DIFFERENTIALSFemur Injuries and Fractures Quadriceps Injury
|
| Drug Name | Acetaminophen (Tylenol, Feverall, Aspirin Free Anacin) |
|---|---|
| Description | Ordinarily, the most commonly ingested pain reliever. Also marketed in combination with other drugs to provide analgesia. Advantages include availability, cost, and relatively high safety profile. The onset of relief usually is within 20-30 min. Extended release preparations do not appear to offer major benefits (other than dosing convenience) and may increase the incidence of toxicity. For children, acetaminophen is available as drops (80 mg/0.8 mL), elixirs (160 mg/5 mL), tablets (80 mg, 160 mg, 325 mg), and suppositories (125 mg, 325 mg). |
| Adult Dose | 650-1000 mg PO q4h; not to exceed 4,000 mg/d PO |
| Pediatric Dose | 10-15 mg/kg/dose PO q4-6h |
| Contraindications | Documented hypersensitivity; known G-6-P deficiency |
| Interactions | Rifampin can interact to reduce the analgesic effects of acetaminophen; conversely, barbiturates, carbamazepine, alcohol, hydantoins, zidovudine, and isoniazid may increase acetaminophen hepatotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Use with care in patients who are malnourished; hepatotoxicity can occur in those with chronic alcoholism following various dosage levels |
Recent controversial data on NSAIDs exist. By suppressing the initial inflammatory reaction, the NSAID permits improved performance in early time periods but appears to suppress the stimulus that may be needed for cellular remodeling in longer time periods. NSAIDs also may increase the amount of bleeding within the tissue. Currently, there is a lack of compelling evidence for either argument.
Although acetaminophen typically is listed with NSAIDs, it lacks anti-inflammatory properties and is used for its antipyretic and analgesic effects.
A number of NSAIDs are available for use. NSAIDs share a common mechanism of action, inhibiting the production of pain-mediating prostaglandins. Generally, NSAIDs provide a comparable degree of pain and inflammatory relief, but they differ in dosing schedule.
The 5 categories of marketed NSAIDs are acetic acid derivatives, fenamates, oxicams, propionic acid derivatives, and related compounds. Numerous NSAIDs are obtainable over-the-counter (OTC). Choosing a NSAID to prescribe can be difficult because little data exists that compares these agents, and individual responses are inconsistent. With a lack of evidence that one NSAID proves to be clearly superior, base decisions on personal experience, safety profiles, cost, and convenience.
| Drug Name | Indomethacin (Indocin) |
|---|---|
| Description | Rapidly absorbed; metabolism occurs in liver by demethylation, deacetylation, and glucuronide conjugation; inhibits prostaglandin synthesis. |
| Adult Dose | 25-50 mg PO bid/tid 75 mg SR PO bid; not to exceed 200 mg/d |
| Pediatric Dose | 1-2 mg/kg/d divided PO bid/qid; not to exceed 4 mg/kg/d or 150-200 mg/d |
| Contraindications | Documented hypersensitivity; GI bleeding or renal insufficiency |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related side effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Category D in third trimester of pregnancy; acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; reversible leukopenia may occur, (discontinue if there is persistent leukopenia, granulocytopenia, or thrombocytopenia) |
| Drug Name | Ketorolac (Toradol) |
|---|---|
| Description | Has become the choice of parenteral pain medications dispensed in the ED. Frequently overlooked is the fact that this medication is an NSAID, carrying all its attendant risks, and it is almost 20 times the cost of morphine (and 140 times the cost of ibuprofen). Little data supporting its superiority over other analgesics exist. |
| Adult Dose | 10 mg PO q6h prn 15-30 mg IV/IM q6h prn, give IV dose over 15-30 sec; not to exceed 5 d of treatment |
| Pediatric Dose | <16 years: 0.5 mg/kg/dose IV/IM q6h; not to exceed 30 mg q6h >16 years: Administer as in adults |
| Contraindications | Documented hypersensitivity; do not administer into CNS; do not administer to patients diagnosed with peptic ulcer disease, recent GI bleeding or perforation, and renal insufficiency or to those patients at high risk of bleeding |
| Interactions | Administered concurrently with aspirin increases the risk of inducing serious NSAID-related side effects; probenecid may increase the concentrations and possibly the toxicity of NSAIDs; may prolong PT when administered concurrently with anticoagulants; closely monitor PT, and instruct patients to watch for signs and symptoms of bleeding; may increase the risk of methotrexate toxicity (eg, stomatitis, bone marrow suppression, nephrotoxicity); phenytoin levels may be increased when administered concurrently |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases the risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; low WBC counts rarely occur and usually return to normal in ongoing therapy; discontinuation of the therapy may be necessary if persistent leukopenia, granulocytopenia, or thrombocytopenia occur Perform ophthalmologic studies in patients who develop eye complaints during therapy; therapy should be discontinued if changes are noted; changes may include blurred or diminished vision, corneal deposits, retinal disturbances, scotomata, changes in color vision, and macular degeneration |
| Drug Name | Ibuprofen (Motrin, Advil, Nuprin) |
|---|---|
| Description | This prevalently used NSAID, also available OTC, is a derivative of the propionic class of NSAIDs and is considered the safest of the NSAIDs. Available as tablets of 200 mg, 400 mg, 600 mg, and 800 mg. Pediatric dosage forms are available as both a tablet and oral suspension (20 mg/mL). Advise taking ibuprofen with food or milk, if possible. Prescribe with caution in children with flulike illnesses. |
| Adult Dose | 400-600 mg PO q6h Alternative dosing: 800 mg PO q8h |
| Pediatric Dose | 30-50 mg/kg/d PO divided qid; not to exceed 2400 mg/d |
| Contraindications | Documented hypersensitivity; because of potential cross-sensitivity to other NSAIDs, do not give these agents to patients in whom aspirin, iodides, or other NSAIDs induce hypersensitivity; do not administer to patients diagnosed with peptic ulcer disease, recent GI bleeding or perforation, and renal insufficiency or to those patients at high risk of bleeding |
| Interactions | Increased toxicity if used with oral hypoglycemic agents, phenytoin, and warfarin; interferes with ACE inhibitors and beta-blockers; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of loop diuretics when administered concurrently; PT may increase when administered concurrently with anticoagulants; closely monitor PT, and instruct patients to watch for signs and symptoms of bleeding; ibuprofen and other NSAIDs may increase serum phenytoin and lithium levels as well as risk of methotrexate toxicity |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Caution in congestive heart failure, hypertension, and decreased renal and hepatic function |
Patients complaining of inadequate pain relief from NSAIDs may benefit from short-term supplementation with an opioid compound. A wide array of products is available.
Orally, hydrocodone (eg, Lortab, Lorcet, Vicodin, Anexsia), a schedule III narcotic, and oxycodone (eg, Roxicet, Percodan, Tylox), a schedule II substance, usually provide additional pain relief. Codeine-containing products (schedule III drugs) are not as reliable for alleviating pain. While the relative potency for oxycodone and hydrocodone is approximately 0.33 (compared with parenteral morphine), oral codeine is 0.05. Mixed agonist-antagonist oral agents, such as butorphanol, nalbuphine, and pentazocine, offer no real advantages to opioid agents; yet, they cause a higher incidence of adverse effects. Common side effects include constipation, nausea, respiratory depression, sedation, and urinary retention.
Generally, the approved dosage of hydrocodone is 5-10 mg, combined with 500-750 mg of acetaminophen and taken PO q6h prn. Oxycodone analgesic preparations typically combine 2.5-5 mg of oxycodone with 325 mg of acetaminophen. They are dosed as 1-2 tab PO q4h prn for moderate to severe pain. Acetaminophen with codeine (Tylenol #3) contains 30 mg of codeine with 325 mg of acetaminophen. Usually, 1-2 pills q4h prn is recommended.
Elixirs containing hydrocodone (Hycodan) are convenient for children older than 6 years who have moderate to severe pain and who are unable to swallow pills. One teaspoon (5 mL) of Hycodan contains 5 mg of hydrocodone; the dose usually is 1.25-2.5 mg q4h, depending on the child's size and the severity of pain. The elixir of Tylenol with codeine for children contains 120 mg of acetaminophen and 12 mg/5 mL of codeine in an alcohol base (7%).
Generally, orally administered drugs impart a slower onset of action. For patients in severe pain or for those patients who must take nothing by mouth (NPO), parenteral agents may be necessary. Although the IM route may be more convenient for the staff, the IV route offers a number of advantages. Narcotics given IV provide a rapid and predictable onset of action and are easier to titrate. Morphine and meperidine are the most commonly used parenteral narcotic agents.
| Drug Name | Hydrocodone and acetaminophen (Vicodin, Lorcet, Lortab, Anexsia) |
|---|---|
| Description | A drug combination indicated for the relief of moderate to severe pain. |
| Adult Dose | 1-2 tab or cap PO q4-6h prn |
| Pediatric Dose | <12 years: 10-15 mg/kg/dose acetaminophen PO q4-6h prn; not to exceed 2.6 g/d of acetaminophen >12 years: 750 mg acetaminophen PO q4h Single dose not to exceed 10 mg of hydrocodone bitartrate; do not exceed 5 doses in 24 h |
| Contraindications | Documented hypersensitivity to acetaminophen or hydrocodone bitartrate; patients with elevated intracranial pressure |
| Interactions | Phenothiazines may decrease its analgesic effects; conversely, the toxicity increases when administered concurrently with CNS depressants or tricyclic antidepressants |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Tablets contain metabisulfite, which may cause allergic reactions; administer with caution in patients dependent on opiates since this substitution may result in acute opiate withdrawal symptoms; exercise caution when patients have severe renal or hepatic dysfunction; use with caution in elderly persons |
| Drug Name | Oxycodone and acetaminophen (Percocet, Tylox, Roxicet) |
|---|---|
| Description | Drug combination indicated for the relief of moderate to severe pain. |
| Adult Dose | 1-2 tab or cap PO q4-6h prn |
| Pediatric Dose | 0.05-0.15 mg/kg/dose oxycodone PO; not to exceed 5 mg/dose of oxycodone q4-6h prn |
| Contraindications | Documented hypersensitivity |
| Interactions | Phenothiazines may decrease the analgesic effects of this medication; conversely, its toxicity increases when administered concurrently with either CNS depressants or tricyclic antidepressants |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Duration of action may increase in elderly persons; be aware of the patient's total daily dose of acetaminophen; maximum dose of acetaminophen is 4000 mg/d, higher doses may cause liver toxicity |
| Drug Name | Acetaminophen and codeine (Tylenol #3) |
|---|---|
| Description | A drug combination indicated for the treatment of mild to moderate pain. |
| Adult Dose | 30-60 mg/dose PO (based on codeine content) q4-6h or 1-2 tab q4h; not to exceed 12 tab/24h |
| Pediatric Dose | 0.5-1 mg/kg/dose PO (based on codeine content) and 10-15 mg/kg/dose PO q4h (based on acetaminophen content); not to exceed 2.6 g/24h |
| Contraindications | Documented hypersensitivity to acetaminophen or codeine phosphate |
| Interactions | Toxicity increases when administered concurrently with CNS depressants or tricyclic antidepressants |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Administer with caution in patients dependent on opiates since this substitution may result in acute opiate withdrawal symptoms; exercise caution when patients have severe renal or hepatic dysfunction |
Contusions, in particular quadriceps contusions, should be observed closely after injury until the hemorrhage has stopped, which usually occurs 24-48 hours after the injury. Considering compartment syndrome or muscle rupture is important if the pain or girth of the affected area has not stabilized by 48 hours postinjury.
No objective data indicate when an athlete may safely return to competition. Each case must be evaluated on an individual basis, and the clinician' s best judgment must act as a guide. In general, if athletes have 90% of strength on the affected side and are able to perform the required activity without any pain or obvious deficits, they are ready to return to the field.
Myositis ossificans occurs in 9% of all contusions, 4% of mild contusions, 13% of moderate contusions, and 18% of severe contusions. Development of myositis ossificans is a multifactorial problem. Reinjury is a significant factor in prolonging disability.
Rhabdomyolysis must be considered if the contusions are extensive or multiple.
The most serious complication is compartment syndrome. Pain out of proportion to the injury or increasing pain over time are red flags that should alert and prompt the physician to measure the compartment pressures.
The use of protective equipment has helped reduce the incidence of contusions, and the athlete must be instructed on proper use of protective equipment.
Some data indicate Indocin can help in decreasing heterotopic bone formation. To date, the data is inconclusive, but this may be considered when selecting a medication with which to treat a patient.
For most muscle contusions, prognosis is excellent. Jackson's research on thigh contusions found the average disability time was 13 days for mild contusions, 19 days for moderate contusions, and 21 days for severe contusions.
Risk factors for a more unfavorable prognosis include injuries that occur during football, previous contusion in the same muscle, delay in treatment for more than 3 days, and large muscle involvement. Reinjury is a significant factor in prolonging disability.
Education about proper use of protective equipment and aggressive early treatment of contusions is essential.
For excellent patient education resources, visit eMedicine's Skin, Hair, and Nails Center and Eye and Vision Center. Also, see eMedicine's patient education articles Bruises and Black Eye.
Article Last Updated: Dec 8, 2005